To further test the function of BRD9 in cancer, we knocked down BRD9 expression in four breast and ovarian cancer cell lines with short hairpin RNAs (shRNAs) (Fig. 8f), then analyzed cell growth in both anchorage-dependent (Fig. 8g) and -independent (Fig. 8h) conditions. Here, BRD9 is linked to ovarian carcinoma.